Cancer Patients

10

Review clinical trials related to Cancer Patients. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis

Background and Study Rationale Immune checkpoint inhibitors (ICI) are a breakthrough cancer treatment that boosts the immune system to fight tumors. While effective, they can cause immune-related side effects, including liver inflammation (ICI-induced hepatitis or CHILI), which affects up to 25% of patients. Severe cases requiring treatment discontinuation are rare but challenging to manage. Study Objective This multicenter prospective study aims to better understand CHILI, its clinical patterns, treatment response, and risk of recurrence. It will focus on different types of liver injury (cholestatic, hepatocellular, or mixed) to guide better treatment decisions. Innovation and Approach Currently, there is no clear consensus on how to manage CHILI or when to safely restart immunotherapy. This study will collect real-world data from adult patients treated with ICIs, following international guidelines or a pragmatic approach when no consensus exists. Findings will help improve care strategies for patients experiencing ICI-related liver toxicity.

Participants needed: 250
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, MontpellierUpdated: Jun 18, 2026Locations: 1Duration: 12 Months
Eligibility criteria

Age ≥ 18 years [+7]

Patient with another cause of acute hepatitis, including viral, autoimmune, isch... [+3]

Status: Recruiting

Impact of ICCAN on Cancer Treatment Completion and Quality of Life

The purpose of this study is to see if the ICCAN program is working, and to compare the ICCAN program to the standard hospital services provided in New York City hospitals, like meeting with a Social Worker or a Patient Navigator (a person who provides personal hospital guidance).

Participants needed: 347
Trial details
Age: 21-80Biological sex: AllType: ObservationalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Jun 12, 2026Locations: 11
Eligibility criteria

fluent in English, Spanish, or Mandarin [+30]

Diagnosed with Stage IV disease [+12]

Status: Recruiting

Effect of Diosmin/Hesperidin Combination on Platinum Compounds-Induced Nephropathy in Cancer Patients

The current study aims to investigate the protective properties of diosmin/hesperidin on cisplatin-induced nephrotoxicity.

Participants needed: 100
Trial details
Phase: Phase 4Age: 18-75Biological sex: AllType: InterventionalSponsor: Beni-Suef UniversityUpdated: May 20, 2026Locations: 1
Eligibility criteria

Patients of 18 to 75 year-age must have histologically or cytologically confirme...

-History of allergic reactions attributed to drugs in the study. [+6]

Status: Recruiting

Writing Intervention With Adolescents and Young Adults With Cancer

Young people with cancer have difficult experiences and writing exercises may help improve their well-being. However, very few studies have examined how a creative writing activity might be useful for young people with cancer. In this pilot study, researchers at St. Jude Children's Research Hospital hope to explore whether teenagers and young adults with cancer want to participate in a writing exercise and whether they find it to be valuable. Primary Objective To assess the feasibility and acceptability of a writing-based narrative medicine intervention for adolescent and young adult patients with cancer.

Participants needed: 26
Trial details
Age: 15-25Biological sex: AllType: InterventionalSponsor: St. Jude Children's Research HospitalUpdated: May 8, 2026Locations: 1
Eligibility criteria

Aged 15-25 [+3]

Does not meet the inclusion criteria [+1]

Status: Not yet recruiting

Exercise and Mindfulness Intervention for Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer

The goal of this clinical trial is to learn whether an exercise- and mindfulness-based cognitive therapy intervention can improve physical and psychological symptoms in cancer patients with chemotherapy-induced peripheral neuropathy. It will also examine whether this intervention can improve quality of life. The main questions it aims to answer are: Can this intervention reduce physical symptoms related to chemotherapy-induced peripheral neuropathy? Can this intervention reduce psychological symptoms in affected patients? Can this intervention improve patients' quality of life? Participants will: Follow a structured program of regular exercise and mindfulness practice Undergo weekly assessments of symptom changes Keep records of their symptom changes during the intervention period

Participants needed: 40
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Nanjing Medical UniversityUpdated: Apr 29, 2026
Eligibility criteria

Patients with a pathologically confirmed malignant tumor; [+5]

Presence of other neurological diseases or severe psychiatric disorders; [+4]

Status: Not yet recruiting

Individualized Care Perceptions of Patients Receiving Outpatient Chemotherapy: A Qualitative Study

The purpose of this observational study is to learn how people receiving chemotherapy in a clinic without staying overnight (outpatient) feel about the care they receive. The study focuses on individualized care, which means nursing care that is tailored specifically to each person's unique needs, values, and lifestyle. Background: Cancer treatment often involves chemotherapy (medicine used to kill cancer cells). While these treatments help fight the disease, they can also cause side effects like nausea or tiredness, which affect daily life. Nurses play a key role in helping people manage these effects. This research aims to understand how "individualized care" helps participants feel valued and supported during their treatment journey. The study aims to answer these key questions: How do participants describe their experiences with nursing care? What are the specific needs and expectations of these individuals for care that feels personal to them? How does personalized care affect their ability to manage symptoms and follow their treatment plan? Scope and Setting: This study will take place at the Yalova Training and Research Hospital within the Outpatient Chemotherapy Unit. The research will be conducted between May 1, 2026, and April 1, 2027. Method and Participants: The researchers plan to interview 10 to 20 participants who are over 18 years old and receiving treatment at the clinic. The final number of participants will be decided when the researchers find that no new information or themes are being discovered in the interviews (a stage called "data saturation"). Participants will: Take part in a private, one-on-one interview with a researcher. Answer open-ended questions about their thoughts and feelings regarding their nursing care. Allow the interview to be voice-recorded to ensure all information is captured accurately. Spend approximately 30 to 45 minutes sharing their personal experiences. Privacy and Ethics: Participant privacy is a top priority. All personal information and voice recordings will be kept strictly confidential. In the final report, fake names (aliases) will be used so that no one can be identified. Participants can choose to leave the study at any time. The study follows international ethical rules to protect the rights of every participant.

Participants needed: 10
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University of YalovaUpdated: Apr 23, 2026Locations: 1
Eligibility criteria

Continuing treatment at the Outpatient Chemotherapy Unit of the relevant hospita... [+3]

Not receiving ongoing treatment at the Outpatient Chemotherapy Unit of the relev... [+2]

Status: Recruiting

A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers

The purpose of this study is to find out if an anxiety treatment program is practical and effective for Latino older adults with cancer (OACs) and their caregivers.

Participants needed: 60
Trial details
Age: 40+Biological sex: AllType: InterventionalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Mar 6, 2026Locations: 7
Eligibility criteria

As per medical record or self-report, is currently age 65 years or older [+10]

As per medical record or self-report, currently receiving psychotherapy [+10]

Status: Recruiting

A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their Pain

The are doing this study to find out whether using topical (on the skin) herbal plasters, Tibetree pain- relieving plasters (PRPs), can be an effective addition to standard opioid therapy for pain management. The researchers will look at whether the Tibetree PRPs are a practical (feasible) and effective way of managing localized pain (pain that is limited to a certain area) in people who are currently taking opioids. Participants in this study will have cancer or have had it in the past.

Participants needed: 150
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Mar 4, 2026Locations: 7
Eligibility criteria

English speaking with age ≥ 18 years or older [+7]

Patients are unwilling to reduce opioid use if their pain reduces [+10]

Status: Recruiting

Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity

The overarching purpose of this study is to assess whether patients will use the app throughout treatment on a regular basis, as the ultimate goal is to provide an educational platform that can impact patient behaviors and understanding towards health.

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Montefiore Medical CenterUpdated: Feb 24, 2026Locations: 1
Eligibility criteria

Diagnosis of invasive malignancy of the brain, head and neck region, lung, breas... [+7]

Metastatic cancer [+4]

Status: Recruiting

Bilateral Ultrasound Guided Intramuscular Quadratus Lumborum Plane Block Versus Bilateral Lateral Quadratus Lumborum Plane Block in Controlling Postoperative Pain in Cancer Patients Undergoing Open Nephrectomy

This study aims to evaluate the efficacy of bilateral ultrasound-guided intramuscular quadratus lumborum plane block (QL4) versus bilateral lateral quadratus lumborum plane block (QL1) in controlling postoperative pain in cancer patients undergoing open nephrectomy.

Participants needed: 90
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: National Cancer Institute, EgyptUpdated: Mar 21, 2025Locations: 1
Eligibility criteria

Age from 18 to 65 years. [+4]

Patient refusal. [+9]